HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites
 

AbbVie NEWS

NFE/5.0en-USnews-webmaster@google.com2019 Google Inc.Tue, 15 Jan 2019 03:23:05 GMTGoogle News
AbbVie - Stemcentrx Impairment, A Worrying Sign?  Seeking Alpha

AbbVie started the year on a bad note as it basically has written down the value of a fairly recent multi-billion acquisition. Reality is that enormous cash flo.

Seeking Alpha
AbbVie Inc. (ABBV) Dips 2.84% for January 14  Equities.com

AbbVie Inc. is a AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the ...

Equities.com
Rep. Cummings opens investigation into drug prices  Seeking Alpha

Following through on his previously announced commitment, U.S. Representative Elijah Cummings (D-MD 7th District), Chairman of the House Oversight ...

Seeking Alpha
3 Big Reasons Why AbbVie Isn't Worried About Humira  The Motley Fool

Concerned about biosimilar competition for the world's top-selling drug? AbbVie isn't.

The Motley Fool
3 Merck or AbbVie: Which Has the More Robust Revenue Trajectory?  Market Realist

During its third-quarter earnings conference presentation, Merck & Co. (MRK) announced a change in its 2018 revenue forecast range from $42.0 billion–$42.8 ...

Market Realist
AbbVie Inc. (ABBV) Management Presents at 37th Annual J.P. Morgan Healthcare Brokers Conference (Transcript)  Seeking Alpha

AbbVie Inc. (NYSE:ABBV) 37th Annual J.P. Morgan Healthcare Conference January 09 2019, 11:30 AM ET Company Participants Mike Severino - Vice ...

Seeking Alpha
AbbVie Stemcentrx failure signals trouble ahead for CEO Gonzalez  Crain's Chicago Business

CEOs who make bad deals flunk their most important test—investing shareholders' money well. Yet the Stemcentrx fiasco may increase pressure on AbbVie's ...

Crain's Chicago Business
2 Analysts' Recommendations for AbbVie in January  Market Realist

On January 10, AbbVie (ABBV) closed at $88.20, 0.44% higher than its previous closing price. The company closed at a premium of 13.81% to its 52-week low ...

Market Realist
Renaissance Technologies LLC Lowers Position in AbbVie Inc (ABBV)  Fairfield Current

Renaissance Technologies LLC trimmed its position in shares of AbbVie Inc (NYSE:ABBV) by 48.4% during the 3rd quarter, according to its most recent Form ...

Fairfield Current
AbbVie Joins Rank Of Stocks With 95-Plus Composite Rating  Investor's Business Daily

On Friday, AbbVie (ABBV) got an upgrade for its IBD SmartSelect Composite Rating from 87 to 96. X. Error loading player: No playable sources found.

Investor's Business Daily
AbbVie Partners Lupin to Boost Hematological Cancer Pipeline  Zacks.com

AbbVie (ABBV) enters into partnership with India-based Lupin, gaining exclusive rights to develop and commercialize the latter's investigational MALT1 ...

Zacks.com
Is AbbVie (ABBV) a Great Value Stock Right Now?  Zacks.com

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless ...

Zacks.com
Abbvie to record $4 billion impairment charges on Stemcentrx assets  Reuters

(Reuters) - Abbvie Inc on Friday said bit.ly/2F9iUlb it will record an estimated $4 billion in impairment charges related to the scrapping of its development ...

Reuters
AbbVie: This Dividend Aristocrat Offers Double-Digit Total Return Potential  Seeking Alpha

Despite risks, Abbvie's dividend is well-covered and appears safe. There is a reasonably high probability that Abbvie's drug pipeline is strong enough to replac.

Seeking Alpha
Alector IPO: AbbVie Is Helping, But It Is At Early Stage Of Development  Seeking Alpha

Alector focuses on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Currently, with two product candidates, AL001 and ...

Seeking Alpha
3 Top Dividend Stocks Selling at a Discount Right Now  Motley Fool

There's at least one positive result from the stock market correction over the past few months. Great dividend stocks can be bought at great discounts. Even better ...

Motley Fool
AbbVie takes $4B impairment charge on Stemcentrx  BioPharma Dive

After a Phase 3 trial setback last month, AbbVie began evaluating Stemcentrx's intangible assets to estimate an impairment charge, which the pharma has ...

BioPharma Dive
Top Analyst Reports for Visa, Coca-Cola & AbbVie  Zacks.com

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, ...

Zacks.com
Ex-Dividend Reminder: Publix Super Markets, AbbVie and Quest Diagnostics  Nasdaq

Looking at the universe of stocks we cover at Dividend Channel , on 1/14/19, Publix Super Markets Inc (Symbol: PUSH), AbbVie Inc (Symbol: ABBV), and Quest ...

Nasdaq
AbbVie Earns Technical Rating Upgrade  Investor's Business Daily

On Thursday, AbbVie (ABBV) earned a positive adjustment to its Relative Strength (RS) Rating, from 67 to 73. X. Error loading player: No playable sources found.

Investor's Business Daily
AbbVie to record $4B impairment charge on Stemcentrx acquisition  Seeking Alpha

Abbvie (ABBV) discloses it will record ~$4B in impairment charges related to its decision to halt its development program of investigational cancer therapy.

Seeking Alpha
AbbVie (ABBV) Outpaces Stock Market Gains: What You Should Know  Zacks.com

AbbVie (ABBV) closed at $90.40 in the latest trading session, marking a +1.49% move from the prior day.

Zacks.com
AbbVie (ABBV) Inks Immunotherapy Deal with Private Biotech  Zacks.com

AbbVie (ABBV) inks deal with Tizona Therapeutics, to develop and commercialize CD39-targeted therapeutics, including TTX-030, which is a first-in-class ...

Zacks.com
Will AbbVie (ABBV) Shares Regain Lost Momentum in 2019?  Zacks.com

Though AbbVie's (ABBV) stock was down this year, it looks well poised for a recovery in 2019.

Zacks.com
AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib  Zacks.com

AbbVie (ABBV) submits regulatory applications in the United States and EU for upadacitinib, for the treatment of adult patients with moderate to severe ...

Zacks.com
Better Buy: AbbVie vs. Merck  The Motley Fool

Which stock wins in a head-to-head matchup between these two big drugmakers?

The Motley Fool
Have traders Expected an Awful Movement in these stocks? AbbVie Inc. (ABBV), Masco Corporation (MAS)  NMSU Nеws

The shares of AbbVie Inc. (NYSE:ABBV) went up during the trading session by $0.11 on Friday, trading at $88.31. The stock has a 52-week low of $77.50 while ...

NMSU Nеws
AbbVie Strikes Deal With Lupin for Blood Cancer Program  BioSpace

AbbVie closed out 2018 by striking a nearly $1 billion licensing deal for India-based Lupin Limited's MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma ...

BioSpace
AbbVie puts up $105M for Tizona's preclinical I/O drug  BioPharma Dive

AbbVie has paid $105 million upfront to secure exclusive global rights to Tizona's Therapeutics' research into CD39-targeted therapies, including the preclinical ...

BioPharma Dive
AbbVie teams up with Voluntis in companion digital therapeutics  Seeking Alpha

AbbVie (ABBV +2.1%) will collaborate with healthcare software developer Voluntis to develop a solution designed to enhance the coordination of patient care in ...

Seeking Alpha
The Zacks Analyst Blog Highlights: Visa, Coca-Cola, AbbVie, Johnson & Johnson and Duke Energy  Nasdaq

For Immediate ReleaseChicago, IL - January 9, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity.

Nasdaq
AbbVie and Tizona Therapeutics Announce Strategic Collaboration to Develop First-in-Class Immunotherapy for Cancer Targeting CD39  PRNewswire

NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif., Jan. 3, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical ...

PRNewswire
AbbVie Inc. (ABBV) stock price traded 0.79% higher to its SMA-20  Wall Street Morning

Technical analysis of AbbVie Inc. (ABBV) stock is the study of technical indicators and past trends. For technical analysis of stock and trends here we employ the ...

Wall Street Morning
Notable Analyst's Ranking Preview: AbbVie Inc. (ABBV)  Nasdaq Click

AbbVie Inc. (ABBV) stock figure shut its day with gain 0.12% and conclude at the price of $88.31, its 52 week- top value and changed 13.95% from its 52 ...

Nasdaq Click
Analysts' Review :: AbbVie Inc., (NYSE: ABBV)  Global Export Lines

Earnings for each Share (EPS) are the part of a company's profit allocated to respectively outstanding share of common stock. EPS serves as a pointer to a ...

Global Export Lines
AbbVie (ABBV) Stock Moves -0.79%: What You Should Know  Zacks.com

AbbVie (ABBV) closed at $84.93 in the latest trading session, marking a -0.79% move from the prior day.

Zacks.com
Could Gilead, Amgen and AbbVie follow Bristol-Myers into megadeal territory?  FiercePharma

Bristol-Myers Squibb's Thursday announcement that it would nab Celgene for $74 billion brought “megamergers back to pharma,” as Credit Suisse analyst ...

FiercePharma
Championed by AbbVie, immuno-neurology player Alector maps $150M IPO  Endpoints News

Endorsed by AbbVie, and under the leadership of Genentech veteran Arnon Rosenthal, San Francisco-based biotech Alector has charted a path toward a $150 ...

Endpoints News
AbbVie Inc. Increases Dividend by 11.46%  Dividend.com

Check out securities going ex-dividend this week with an increased payout .

Dividend.com
AbbVie Promotes GC to Vice Chairwoman, CLO in Executive Restructuring | Corporate Counsel  Law.com

North Chicago-based pharmaceutical company AbbVie Inc. has announced that its general counsel Laura Schumacher was promoted to the role of vice ...

Law.com
Ashfield Capital Partners Upped Abbvie (ABBV) Stake; Ftb Advisors Has Cut Its Genuine Parts Co (GPC) Holding by $6.41 Million; Shares Declined  The Moveefy

Ashfield Capital Partners Llc increased its stake in Abbvie Inc (ABBV) by 3.97% based on its latest 2018Q3 regulatory filing with the SEC. Ashfield Capital ...

The Moveefy
Lupin and AbbVie Announce Partnership to Develop and Commercialize Novel Oncology Drug to Treat Hematological Cancers  Associated Press

MUMBAI, India--(BUSINESS WIRE)--Dec 24, 2018--Pharma major Lupin Limited (Lupin) and global biopharmaceutical company AbbVie Inc., today announced ...

Associated Press
AbbVie's Humira holds on to TV ad crown in December despite Pfizer's year-end Xeljanz push  FiercePharma

Could Pfizer's Xeljanz become the 2019 challenger to AbbVie's Humira TV ad crown? The Pfizer anti-inflammatory drug, now boasting three indications, spent ...

FiercePharma
Stock-research Ratings: AbbVie Inc. (ABBV), Popular, Inc. (BPOP)  Analyst Journal

AbbVie Inc. (NYSE:ABBV) tinted gains of +0.12% (+0.11 points) to US$88.31. The volume of 5.31 Million shares climbed down over an trading activity of 7.18 ...

Analyst Journal
Tarbox Group Lowered Abbvie (ABBV) Holding by $561,274 as Stock Price Declined; Quidel (QDEL) Stock Price Declined While Renaissance Technologies Has Lowered Holding by $9.11 Million  The Moveefy

Tarbox Group Inc decreased its stake in Abbvie Inc (ABBV) by 12.75% based on its latest 2018Q3 regulatory filing with the SEC. Tarbox Group Inc sold 5,971 ...

The Moveefy
AbbVie revamps senior management  Seeking Alpha

With an eye on the future, AbbVie ([[ABBV]]) chief Rick Gonzalez has pared his number of direct reports to four: EVP of R&D and Chief Scientific Officer Mi.

Seeking Alpha
AbbVie Inc. (ABBV) Stock Regains Attentions on Moves of SMA  Investing News Update

AbbVie Inc. (ABBV) making a luring appeal, share price swings at $88.31 with percentage change of 0.12% during Friday trading session. Along recent up drift, ...

Investing News Update
Top Stocks Reports for McDonald's, AbbVie & Altria  Zacks.com

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, ...

Zacks.com
As Patent Expirations Loom, the Clock Is Ticking on AbbVie Stock  Investorplace.com

AbbVie is doing all it can to keep Humira sales high, but competition and regulation mean the party could be ending for AbbVie stock.

Investorplace.com
Drugs for Rheumatoid Arthritis Market 2019 Precise Outlook – AbbVie Inc, Hoffman-La Roche AG, Amgen Inc, Pfizer Inc  Bitcoin Journal

The research report presents a comprehensive assessment of the Drugs for Rheumatoid Arthritis market and contains thoughtful insights, facts, historical data, ...

Bitcoin Journal
AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV  Nasdaq

InvestorPlace - Stock Market News, Stock Advice & Trading TipsWhen most people think about cannabis stocks, AbbVie (NYSE: ABBV ) doesn't.

Nasdaq
Global Cytokines Market 2019 - AbbVie, Johnson & Johnson, GlaxoSmithKline, Novartis, Roche, Pfizer, Sanofi, Bayer HealthCare Pharmaceuticals  Industry News Alert

The global Cytokines market research report comprises of the basic insights that are relevant to the global market. The report being an all-inclusive one will be of ...

Industry News Alert
AbbVie Strategically Restructures Executive Leadership Team  BioSpace

The new structure creates four top managers who will report directly to the company CEO. All other executives will report to those managers.

BioSpace
AbbVie: A Low-Risk Income Stock That Gives Investors Exposure to the Marijuana Industry  GuruFocus.com

AbbVie Inc. (NYSE:ABBV) is one of the largest biotechnology companies in the world. The immunology-focused company with a vast pipeline offers steady ...

GuruFocus.com
Smith Moore & Company Increases Position in Abbvie (ABBV); Cme Group Class A (CME) Holding Increased by Private Trust Co  The Moveefy

Smith Moore & Company increased its stake in Abbvie Inc (ABBV) by 8.87% based on its latest 2018Q3 regulatory filing with the SEC. Smith Moore & Company ...

The Moveefy
Stocks To Watch Today: AbbVie Inc. (ABBV) And Glu Mobile Inc. (GLUU) On The Marquee  GV Times

The price of AbbVie Inc. (NYSE:ABBV) went up by $0.11 now trading at $88.31. Their shares witnessed a 13.95% increase from the 52-week low price of $77.5 ...

GV Times
Lupin partners with Abbvie to develop and commercialize new targeted oncology treatments  News-Medical.net

Pharma major Lupin Limited and global biopharmaceutical company AbbVie Inc., today announced that AbbVie has licensed Lupin's MALT1 ...

News-Medical.net
AbbVie (ABBV) Submits NDA to US FDA and MAA to EMA for Upadacitinib for Treatment of Adults with Moderate to Severe Rheumatoid Arthritis  StreetInsider.com

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced that it has submitted a New Drug Application (NDA) to the U.S. Food ...

StreetInsider.com
Trend-Spotting Tool in Focus – AbbVie Inc. (NYSE: ABBV)  Alpha Beta Stock

AbbVie Inc. (NYSE: ABBV) stock encountered a rapid change of 0.12% in the last hour of Friday's trading session. The stock settled the final trade on $88.31.

Alpha Beta Stock
AbbVie to Present at the 37th Annual JP Morgan Healthcare Conference  PRNewswire

NORTH CHICAGO, Ill., Dec. 20, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the 37 th ...

PRNewswire
Abbvie (ABBV) Holder Huber Capital Management Boosted Its Position by $1.50 Million as Stock Price Declined; Highlander Capital Management Has Trimmed Its Stake in Fastenal Co (FAST) as Share Price Declined  The Moveefy

Highlander Capital Management Llc decreased its stake in Fastenal Co (FAST) by 96.36% based on its latest 2018Q3 regulatory filing with the SEC. Highlander ...

The Moveefy
Abbvie (ABBV) Shareholder Princeton Portfolio Strategies Group Has Decreased Its Stake; Brooks Automation (BRKS) Stock Declined While John G Ullman & Associates Decreased Stake by $2.69 Million  The Moveefy

Princeton Portfolio Strategies Group Llc decreased its stake in Abbvie Inc (ABBV) by 56.99% based on its latest 2018Q3 regulatory filing with the SEC. Princeton ...

The Moveefy
The Humira Overhang Can’t Cast a Shadow on AbbVie Stock Forever  Investorplace.com

If you're thinking about stepping into AbbVie stock here, you're not crazy. The challenge is getting everyone else to believe in ABBV stock.

Investorplace.com
Showing all their Cards? Abbvie Inc (ABBV) Twiggs Reading in Focus  Hawthorn Caller

Traders will be closely monitoring shares of Abbvie Inc (ABBV) as the Twiggs Money Flow indicator has touched above the zero line, indicating positive ...

Hawthorn Caller
AbbVie (ABBV) Stock Moves -0.89%: What You Should Know  Zacks.com

AbbVie (ABBV) closed the most recent trading day at $84.16, moving -0.89% from the previous trading session.

Zacks.com
The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie  Nasdaq

For Immediate Release Chicago, IL - January 7, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks.

Nasdaq
The Global Biologic Therapeutics Market 2018-2022; Dominated by AbbVie, Johnson & Johnson, Merck, and Pfizer - ResearchAndMarkets.com  Business Wire

DUBLIN--(BUSINESS WIRE)--The "Global Biologic Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The biologic ...

Business Wire
AbbVie Inc (ABBV) Shares Sold by South Texas Money Management Ltd.  Fairfield Current

South Texas Money Management Ltd. reduced its holdings in AbbVie Inc (NYSE:ABBV) by 43.3% in the 3rd quarter, according to its most recent 13F filing with ...

Fairfield Current
Chutes & Ladders—AbbVie streamlines management team to 4 executives  FierceBiotech

AbbVie streamlined its management team to four executives, the FDA tapped Flatiron's Amy Abernethy for an oversight post and PPD beefed up its therapeutics ...

FierceBiotech
Abbvie (ABBV) Position Has Raised by Bank Hapoalim Bm; As Biogen (BIIB) Valuation Declined, Shareholder Supplemental Annuity Collective Trust Of Nj Has Lowered Its Position  The FinExaminer

Bank Hapoalim Bm increased its stake in Abbvie Inc (ABBV) by 74.49% based on its latest 2018Q3 regulatory filing with the SEC. Bank Hapoalim Bm bought ...

The FinExaminer
Abbvie Com (ABBV) Share Price Declined While Rothschild Investment Has Increased Its Holding; As Facebook (FB) Stock Declined, Gvo Asset Management LTD Has Cut Holding by $4.67 Million  The Moveefy

Gvo Asset Management Ltd decreased its stake in Facebook Inc (FB) by 28.32% based on its latest 2018Q3 regulatory filing with the SEC. Gvo Asset ...

The Moveefy
Intersect Capital Cut General Electric Co (GE) Stake by $338,602; As Abbvie (ABBV) Share Price Declined, Shareholder Hamlin Capital Management Has Raised Its Holding  The FinExaminer

Intersect Capital Llc decreased its stake in General Electric Co (GE) by 58.57% based on its latest 2018Q3 regulatory filing with the SEC. Intersect Capital ...

The FinExaminer
Schlumberger LTD (SLB) Shareholder Guardian Investment Management Lowered Holding as Stock Price Declined; As Abbvie (Put) (ABBV) Valuation Declined, Holder Maplelane Capital Has Upped Position  The Moveefy

Maplelane Capital Llc increased its stake in Abbvie Inc (Put) (ABBV) by 125% based on its latest 2018Q3 regulatory filing with the SEC. Maplelane Capital Llc ...

The Moveefy
The Zacks Analyst Blog Highlights: McDonald???s, AbbVie, Altria, Wells Fargo and Disney  Nasdaq

For Immediate Release Chicago, IL -December 18, 2018 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks.

Nasdaq
Lilly's Taltz beats out AbbVie's megadrug Humira in psoriatic arthritis showdown  FiercePharma

What's a surefire way to get noticed in any field? Beat out a behemoth. And that's what Eli Lilly's Taltz has just done in psoriatic arthritis by topping AbbVie's ...

FiercePharma
Technical Review on Shares of AbbVie Inc. (NYSE:ABBV): CMF 20 is -0.05307232  Martin Business Telegraph

Investors may be searching high and low for the next breakout winner in the stock market. As companies continue to release quarterly earnings reports, ...

Martin Business Telegraph
Fairpointe Capital Increased Its Meredith (MDP) Position; Abbvie (ABBV) Share Price Declined While Schaper Benz & Wise Investment Counsel Has Trimmed Position  The Moveefy

Fairpointe Capital Llc increased its stake in Meredith Corp (MDP) by 2.25% based on its latest 2018Q3 regulatory filing with the SEC. Fairpointe Capital Llc ...

The Moveefy
JP Morgan 2019 day three roundup – Abbvie rekindles the takeover flame  Vantage

Day three of the biotech dog and pony show saw one pharma company that unequivocally wants and needs to buy. J.P Morgan 37th annual healthcare ...

Vantage
AbbVie Inc (NYSE:ABBV) Stake Increased by Holderness Investments Co.  Fairfield Current

Holderness Investments Co. boosted its position in shares of AbbVie Inc (NYSE:ABBV) by 11.2% in the 3rd quarter, according to its most recent filing with the ...

Fairfield Current
Abbvie (ABBV) Share Value Declined While Iberiabank Trimmed Its Position; Integrated Device Technology (IDTI) Shareholder Rice Hall James & Associates Lowered Its Position  The Moveefy

Rice Hall James & Associates Llc decreased its stake in Integrated Device Technology Inc. (IDTI) by 9.79% based on its latest 2018Q3 regulatory filing with the ...

The Moveefy
Technical check on AbbVie Inc. (ABBV)  Nasdaq Click

AbbVie Inc. (ABBV) stock figure shut its day with gain 0.44% and conclude at the price of $88.20, its 52 week- top value and changed 13.81% from its 52 ...

Nasdaq Click
As Abbvie (ABBV) Shares Declined, Spectrum Management Group Decreased Its Position by $2.69 Million; Ycg Has Decreased Pepsico (PEP) Stake by $4.25 Million; Valuation Rose  The Moveefy

Ycg Llc decreased its stake in Pepsico Inc (PEP) by 18.19% based on its latest 2018Q3 regulatory filing with the SEC. Ycg Llc sold 38,327 shares as the ...

The Moveefy
Braun Stacey Associates Trimmed Its Abbvie Com (ABBV) Holding by $1.52 Million; Timber Hill Increased Its Chevron (CVX) Stake by $1.73 Million as Valuation Rose  The Yomi Blog

Timber Hill Llc increased its stake in Chevron Corp (CVX) by 307.18% based on its latest 2018Q3 regulatory filing with the SEC. Timber Hill Llc bought 14,155 ...

The Yomi Blog
As Abbvie (ABBV) Market Value Declined, Bridges Investment Management Boosted by $317,156 Its Stake; Miller Howard Investments Has Cut Its Position in Lamar Advertising Co New Cl A (LAMR) as Share Value Declined  The Moveefy

Miller Howard Investments Inc decreased its stake in Lamar Advertising Co New Cl A (LAMR) by 3.53% based on its latest 2018Q3 regulatory filing with the SEC ...

The Moveefy
Globant Ord (GLOB) Shareholder Globeflex Capital LP Lifted Position; As Abbvie (ABBV) Market Value Declined, Ccm Investment Advisers Decreased by $4.26 Million Its Stake  The Yomi Blog

Globeflex Capital LP increased its stake in Globant Ord (GLOB) by 50.04% based on its latest 2018Q3 regulatory filing with the SEC. Globeflex Capital LP ...

The Yomi Blog
Rothschild Investment Has Increased Stake in Abbvie Com (ABBV); Spindletop Capital Has Lowered Svb Finl Group (SIVB) Stake by $4.65 Million  The Yomi Blog

Spindletop Capital Llc decreased its stake in Svb Finl Group (SIVB) by 18.75% based on its latest 2018Q3 regulatory filing with the SEC. Spindletop Capital Llc ...

The Yomi Blog
As Abbvie Com (ABBV) Share Value Declined, Lafayette Investments Increased Holding; Mastercard (MA) Shareholder Security National Trust Co Lifted Its Holding by $468,420 as Stock Value Declined  The Yomi Blog

Security National Trust Co increased its stake in Mastercard Inc (MA) by 18.3% based on its latest 2018Q3 regulatory filing with the SEC. Security National Trust ...

The Yomi Blog
Roumell Asset Management Has Lifted Hc2 Hldgs (HCHC) Stake by $686,580; Summit Financial Wealth Advisors Stake In Abbvie (ABBV) Was Has Boosted  The Moveefy

Roumell Asset Management Llc increased its stake in Hc2 Hldgs Inc (HCHC) by 38.76% based on its latest 2018Q3 regulatory filing with the SEC. Roumell ...

The Moveefy
Twin Tree Management LP Has Cut By $8.57 Million Its Abbvie (Call) (ABBV) Stake; Ws Management Lllp Has Raised By $132.96 Million Its Micron Technology (MU) Holding  The Hi New Ulm

Ws Management Lllp increased Micron Technology Inc (MU) stake by 72.37% reported in 2018Q3 SEC filing. Ws Management Lllp acquired 2.95 million shares ...

The Hi New Ulm
Hot Stock Evaluation – AbbVie Inc. (NYSE: ABBV)  Seekingfin

AbbVie Inc. (NYSE: ABBV) stock experienced a change of 0.12% in final minutes of Friday's trading session. The stock closed the last trade at $88.31. Investors ...

Seekingfin
Smith Asset Management Group LP Has Cut Abbvie (ABBV) Stake by $2.82 Million; Bollard Group Position in Merck & Co (MRK) Has Boosted by $468,930  The Yomi Blog

Smith Asset Management Group Lp decreased its stake in Abbvie Inc (ABBV) by 22.38% based on its latest 2018Q3 regulatory filing with the SEC. Smith Asset ...

The Yomi Blog
Home Depot (HD) Stake Maintained by Palo Capital Inc; Profund Advisors Upped Its Abbvie (ABBV) Position by $4.55 Million  The Moveefy

Palo Capital Inc increased its stake in Home Depot Inc (HD) by 19.08% based on its latest 2018Q3 regulatory filing with the SEC. Palo Capital Inc bought 4,202 ...

The Moveefy
Jolley Asset Management Has Cut Abbvie (ABBV) Holding By $368,480; Jacobs Asset Management Decreased Its Iberiabank (IBKC) Holding  The Yomi Blog

Jacobs Asset Management Llc decreased Iberiabank Corp (IBKC) stake by 7.69% reported in 2018Q3 SEC filing. Jacobs Asset Management Llc sold 12,500 ...

The Yomi Blog
Kite Rlty Group Tr (KRG) Holding Increased by Presima Inc; As Abbvie (ABBV) Stock Value Declined, Holder Putnam Fl Investment Management Co Trimmed Position  The Yomi Blog

Presima Inc increased its stake in Kite Rlty Group Tr (KRG) by 43.1% based on its latest 2018Q3 regulatory filing with the SEC. Presima Inc bought 45,900 ...

The Yomi Blog
Fulton Bank Has Trimmed Cisco Sys (CSCO) Position by $764,688; Stock Price Declined; Jolley Asset Management Lowered Abbvie (ABBV) Position by $368,480; Stock Price Declined  The Moveefy

Fulton Bank decreased its stake in Cisco Sys Inc (CSCO) by 14.83% based on its latest 2018Q3 regulatory filing with the SEC. Fulton Bank sold 15,931 shares ...

The Moveefy
Tarbox Group Cut Its Stake in Abbvie (ABBV) by $561,274; Tompkins Financial Holding in Apple Com (AAPL) Has Lowered as Stock Price Declined  The Yomi Blog

Tarbox Group Inc decreased its stake in Abbvie Inc (ABBV) by 12.75% based on its latest 2018Q3 regulatory filing with the SEC. Tarbox Group Inc sold 5,971 ...

The Yomi Blog
Rockland Trust Co Has Cut Its Stake in Sherwin Williams Co (SHW) by $421,785 as Share Price Declined; Abbvie (ABBV) Shareholder Zurcher Kantonalbank Zurich Cantonalbank Has Decreased Position as Shares Declined  The Moveefy

Rockland Trust Co decreased its stake in Sherwin Williams Co (SHW) by 3.35% based on its latest 2018Q3 regulatory filing with the SEC. Rockland Trust Co ...

The Moveefy
AbbVie Inc (ABBV) Stake Trimmed by Loomis Sayles & Co. L P  BharataPress

Loomis Sayles & Co. L P lowered its position in AbbVie Inc (NYSE:ABBV) by 43.7% in the third quarter, Holdings Channel reports. The fund owned 4,171 shares ...

BharataPress
As Abbvie (ABBV) Market Valuation Declined, Shareholder Kcm Investment Advisors Decreased Stake; Torch Wealth Management Has Trimmed Holding in Mc Donalds (MCD) by $703,738 as Share Value Rose  The Moveefy

Kcm Investment Advisors Llc decreased its stake in Abbvie Inc (ABBV) by 5.26% based on its latest 2018Q3 regulatory filing with the SEC. Kcm Investment ...

The Moveefy
First Horizon Natl (FHN) Holder Ejf Capital Has Raised Holding; As Abbvie (ABBV) Stock Declined, Shareholder Wall Street Access Asset Management Trimmed Its Holding by $419,992  The FinHeadLines

Ejf Capital Llc increased its stake in First Horizon Natl Corp (FHN) by 90.26% based on its latest 2018Q3 regulatory filing with the SEC. Ejf Capital Llc bought ...

The FinHeadLines
 

AbbVie Videos

AbbVie
22:49:49
AbbVie
Introducing AbbVie
23:29:32
Introducing AbbVie
TOP STOCK NOVEMBER 2018! - DEEP STOCK ANALYSIS - ABBVIE
04:14:39
TOP STOCK NOVEMBER 2018! - DEEP STOCK ANALYSIS - ABBVIE
AbbVie Deutschland
17:09:11
AbbVie Deutschland
Inside the Labs of AbbVie Ludwigshafen
17:31:30
Inside the Labs of AbbVie Ludwigshafen
AbbVie Ventures
15:27:38
AbbVie Ventures
How Safe is AbbVie's Dividend?
16:48:02
How Safe is AbbVie's Dividend?
Working at AbbVie in 2017
02:45:34
Working at AbbVie in 2017
Paséate por las oficinas de AbbVie España
08:18:44
Paséate por las oficinas de AbbVie España
A Glimpse Inside the Labs at AbbVie’s Bioresearch Center
00:19:01
A Glimpse Inside the Labs at AbbVie’s Bioresearch Center
 

AbbVie Images

AbbVie Receives FDA Accelerated Approval of Venclexta ...
AbbVie Receives FDA Accelerated Approval of Venclexta ...
AbbVie's HUMIRA® (Adalimumab) Receives First and Only ...
AbbVie's HUMIRA® (Adalimumab) Receives First and Only ...
Humira Logo | www.pixshark.com - Images Galleries With A Bite!
Humira Logo | www.pixshark.com - Images Galleries With A Bite!
AbbVie swoops for Pharmacyclics in $21bn takeover ...
AbbVie swoops for Pharmacyclics in $21bn takeover ...
AMS Advanced Medical Services GmbH | Home
AMS Advanced Medical Services GmbH | Home
UC Analytics, Monitoring & Troubleshooting for Enterprise ...
UC Analytics, Monitoring & Troubleshooting for Enterprise ...
Psoriasis Diagnosis
Psoriasis Diagnosis
B-MS/Pfizer alliance data shows Eliquis benefits over ...
B-MS/Pfizer alliance data shows Eliquis benefits over ...
欧盟加速审查AbbVie丙肝鸡尾酒疗法,药品资讯,快易捷药品交易网
欧盟加速审查AbbVie丙肝鸡尾酒疗法,药品资讯,快易捷药品交易网
Jason Hoppy: Where is he now?
Jason Hoppy: Where is he now?
 

AbbVie WebSites